Table 3.
Association of LUNAR1 and clinical factors with overall survival in patients with CRC.
| Unadjusted HR* (95% CI) | P | Adjusted HR† (95% CI) | P | |
|---|---|---|---|---|
| LUNAR1 level | 3.49 (1.98–6.14) | <0.001 | 2.79 (1.56–4.99) | 0.001 |
| Sex | 0.98 (0.67–1.45) | 0.942 | 0.89 (0.60–1.34) | 0.584 |
| Age | 1.12 (0.76–1.64) | 0.572 | 1.11 (0.75–1.65) | 0.607 |
| Tumour location | 1.25 (0.82–1.73) | 0.763 | 1.03 (0.65–1.69) | 0.902 |
| Tumour size | 1.53 (0.98–2.39) | 0.061 | 1.26 (0.59–2.71) | 0.511 |
| Differentiation status | 2.13 (1.23–3.68) | 0.007 | 1.16 (0.63–2.15) | 0.626 |
| TNM stage | 3.19 (1.43–7.14) | <0.001 | 3.54 (1.54–8.14) | 0.003 |
*Hazard ratios in univariate models.
†Hazard ratios in multivariable models.
Abbreviations: HR, hazard ratio; 95% CI, 95% confidence interval.